American Oriental Bioengineering (AOB) Submits Plan to Cure Stock Price Deficiency
American Oriental Bioengineering, Inc. (NYSE: AOB) today announced that the Company submitted its plan to cure stock price deficiency with respect to the listing standard of the New York Stock Exchange on October 5, 2011.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
You May Also Be Interested In
- Dow Chemical (DOW) Wins $2.16B in K-Dow Arbitration
- Coeur d’Alene (CDE) Announces Resumption of Full Production at Palmarejo Mine
- Bazaarvoice (BV) Agrees to Buy PowerReviews; Offers Prelim. Q1 Results, Guides Q2, FY13
Create E-mail Alert Related Categories
Corporate NewsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
